Clinical Trials

Accrual Status
Limit to SWOG Trials

1028 Results

View
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-7315/16

Remission Induction for Adult Acute Leukemia with Ten-day OAP Remission Maintenance with OAP vs OAP plus BCG
Activated
07-06-1973
Closed
01-01-1977
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-7204/7205

Non-Hodgkin's Lymphoma CHOP vs. HOP Combination Chemotherapy for Remission Induction and COP vs. OAP Combination Chemotherapy for Maintenance
Research Committee(s)
Lymphoma
Activated
04-17-1972
Closed
09-10-1974
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-781

Radiotherapy - Chemotherapy (MOPP) for Stages I and II, A and B Hodgkin's
Activated
02-14-1972
Closed
08-08-1978
Closed
Phase
SWOG Clinical Trial Number
SWOG-780

Combination Cyclophosphamide, Vincristine, Prednisone and Bleomycin for Non-Hodgkin's Lymphoma
Activated
11-04-1971
Closed
02-08-1973
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-774/775

Hodgkin's Disease: Remission Induction with Mustargen, Oncovin, Prednisone and Procarbazine + Bleomycin (MOPP#4)
Activated
07-20-1971
Closed
08-23-1974
Closed
Phase
SWOG Clinical Trial Number
SWOG-160

Combined Radiotherapy and Chemotherapy for Stage II B, Stage III A and Stage III B Hodgkin's Disease
Activated
03-18-1971
Closed
02-21-1975
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-440

Bleomycin for Solid Tumors and Lymphomas
Activated
12-11-1970
Closed
07-01-1971
Closed
Phase
Accrual
91%
SWOG Clinical Trial Number
SWOG-438

Combined 5-Fluorouracil (NSC-19893) and Hydrazine-1- Acetyl-2-Picolinoyl (NSC-68626) Therapy in the Treatment of Adenocarcinoma of the Stomach and Colon and Carcinoid
Activated
06-09-1970
Closed
06-15-1971
Closed
Phase
Accrual
53%
SWOG Clinical Trial Number
SWOG-437

NSC-409962 ... 1, 3-bis(2-chloroethyl)-1-nitrosourea (BCNU) Phase II study ... Advanced Breast Cancer
Activated
01-19-1970
Closed
Phase
SWOG Clinical Trial Number
SWOG-772/773

Hodgkin's Disease: Remission Consolidation with Actinomycin D, Vinblastine, and Methotrexate (MOPP#3)
Activated
10-08-1969
Closed
11-09-1971
Closed
Phase
Accrual
1%
SWOG Clinical Trial Number
SWOG-229

Study of Dibromomannitol in Chronic Granulocytic Leukemia
Activated
08-06-1969
Closed
Phase
Accrual
58%
SWOG Clinical Trial Number
SWOG-434

Imidazole Carboxamide Dimethyl Triazene (NSC-45388) in Patients with Solid Tumors (Excluding Melanomas, Lymphomas, and Breast Cancer)
Activated
05-20-1969
Closed
06-24-1970
Closed
Phase
Accrual
9%
SWOG Clinical Trial Number
SWOG-431

Evaluation of Bis-Chlorethyl-nitrosourea (BCNU) in Multiple Myeloma
Research Committee(s)
Myeloma
Activated
04-16-1969
Closed
Phase
Accrual
0%
SWOG Clinical Trial Number
SWOG-227

Protocol for Phase II Trial of Actinomycin D & Vincristine in Lung Cancer
Activated
08-06-1968
Closed
08-21-1969
Closed
Phase
Accrual
4%
SWOG Clinical Trial Number
SWOG-717

Combination Drug (Cytoxan (NSC-26271), Vincristine (NSC-67574), Methotrexate (NSC-740) and 5-Fluorouracil (NSC-19893) Chemotherapy of Solid Tumor in Adults
Activated
07-29-1968
Closed
Phase
SWOG Clinical Trial Number
SWOG-756/759

Combination Chemotherapy in Advanced Hodgkin's Disease: Induction and Maintenance of Remission
Activated
09-29-1967
Closed
09-01-1973
Closed
Phase
Accrual
93%
SWOG Clinical Trial Number
SWOG-703

Combination for Cyclophosphamide (NSC-26271), Vincristine (NSC-67574) and 5-Fluorouracil (NSC-19893) in the Treatment of Advanced Breast Cancer
Activated
07-21-1967
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
SWOG-226

Phase II Protocol for Porfiromycin Solid Tumors
Activated
07-12-1967
Closed
Phase
Accrual
2%
SWOG Clinical Trial Number
SWOG-427

Cytosine Arabinoside (NSC-63878) in Acute Leukemia in Adults
Activated
07-01-1967
Closed
06-09-1969
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8264

Combination Chemotherapy with m-AMSA, Cis-Platinum and MGBG for Refractory Lymphoma
Activated
08-11-1962
Closed
03-16-1984